Title: Challenges and opportunities in using residual newborn screening samples for translational research
Description: "Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research."
Subjects: Moral and ethical aspects, Newborn infants, Diseases, Diagnosis, Neonatology, Research, Infants (newborn), Neonatal Screening, Ethics, Biomedical Research, Bioethical Issues, Blood Specimen Collection, Inborn Genetic Diseases, Blood Chemical Analysis, Newborn Infant, Translational Medical Research, Public Health